Stockholm - Delayed Quote SEK
Pila Pharma AB (publ) (PILA.ST)
At close: November 6 at 4:55 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-4,854.0000
-4,854.0000
-9,091.0000
-9,364.0000
-2,001.0000
Financing Cash Flow
3,565.0000
3,565.0000
-11,875.0000
35,666.0000
-158.0000
End Cash Position
5,954.0000
5,954.0000
7,243.0000
28,209.0000
1,907.0000
Issuance of Capital Stock
8,562.0000
8,562.0000
6,011.0000
44,082.0000
2,944.0000
Issuance of Debt
--
--
--
--
500.0000
Repayment of Debt
--
--
--
-500.0000
--
Repurchase of Capital Stock
--
--
--
--
-3,602.1740
Free Cash Flow
-4,854.0000
-4,854.0000
-9,091.0000
-9,364.0000
-2,001.0000
12/31/2020 - 7/15/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIOSGN.ST Biosergen AB
0.7100
-1.93%
0QW0.IL argenx SE
555.70
+2.79%
0H22.IL BioInvent International AB (publ)
45.10
+0.84%
ALZ.ST Alzinova AB (publ)
3.4400
-3.37%
ELIC.ST Elicera Therapeutics AB (publ)
1.9050
-3.54%
STABL.ST Stayble Therapeutics AB (publ)
0.7200
-3.36%
SANION.ST Saniona AB (publ)
3.1950
-38.32%
ONCOZ.ST OncoZenge AB (publ)
8.89
-3.47%
PEG.CO Pharma Equity Group A/S
0.1665
+2.15%
EGTX.ST Egetis Therapeutics AB (publ)
4.1000
-0.97%